MedTrace Logo

Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases

NCT05023772 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-06-26

No results posted yet for this study

Summary

The purpose of this research is to combine two complementary modes of treatment, spinal interstitial laser ablation and stereotactic spine radiosurgery (SSRS) for the treatment for spinal tumors near the spinal cord with an objective to improve tumor control, improve pain control, preserve function, and improve quality of life. We will also assess how effective these combined modes of treatment are in patients with spinal metastasis with an epidural component.

Conditions

  • Neoplasm Metastasis
  • Spinal Cord Diseases
  • Spinal Cord Compression
  • Spinal Cord Tumor
  • Spine Metastases

Interventions

PROCEDURE

Stereotactic Laser Ablation

MR Guided laser ablation therapy

RADIATION

Stereotactic Radiosurgery

Precise delivery of radiation to spinal tumor

DIAGNOSTIC_TEST

MRI guided laser ablation

Surgery will take place in intraoperative suite to include operating room and MRI scanner

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Ian Lee, MD · Henry Ford Health Health System

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-02
Primary Completion
2026-06-01
Completion
2026-12-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05023772 on ClinicalTrials.gov